The membrane hypothesis of schizophrenia

The phospholipid structure of neuronal membranes is essential for normal functioning of the nervous system. Evidence is accumulating that phospholipid metabolism in both brain and red blood cells may be disturbed in schizophrenia. In particular, in patients with negative symptoms, levels of arachidonic acid and docosahexanoic acid in red blood cell membrane phospholipids are severely abnormal. The membrane hypothesis of schizophrenia may represent a new and fruitful paradigm for future research.

[1]  S. Mukherjee,et al.  Decreased adhesiveness associated with abnormal growth of cultured skin fibroblasts from schizophrenic patients , 1993, Schizophrenia Research.

[2]  W. Shain,et al.  Neurotransmitter modulation of prostaglandin E1-stimulated increases in cyclic AMP. II. Characterization of a cultured neuronal cell line treated with dibutyryl cyclic AMP. , 1978, Biochemical pharmacology.

[3]  M. Buchsbaum,et al.  Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone , 1979, Psychiatry Research.

[4]  I. Gottesman,et al.  Negative association between schizophrenia and rheumatoid arthritis. , 1991, Schizophrenia bulletin.

[5]  Y. Abdulla,et al.  Effect of ADP on PGE1 Formation in Blood Platelets from Patients with Depression, Mania and Schizophrenia , 1975, British Journal of Psychiatry.

[6]  D. Horrobin.  Nutritional and medical importance of gamma-linolenic acid. , 1992, Progress in lipid research.

[7]  H. Kaiya.  Second messenger imbalance hypothesis of schizophrenia. , 1992 .

[8]  D. Horrobin,et al.  Fatty acid levels in the brains of schizophrenics and normal controls , 1991, Biological Psychiatry.

[9]  J. Rotrosen,et al.  Reduced PGE1 stimulated 3H-cAMP accumulation in platelets from schizophrenics. , 1978, Life sciences.

[10]  D. Piomelli,et al.  Participation of Prostaglandin E2 in Dopamine D2 Receptor‐Dependent Potentiation of Arachidonic Acid Release , 1992, Journal of neurochemistry.

[11]  J. R. Sportsman,et al.  Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. , 1991, The Journal of biological chemistry.

[12]  R. R. Brenner,et al.  Nutritional and hormonal factors influencing desaturation of essential fatty acids. , 1981, Progress in lipid research.

[13]  D. Werman,et al.  Schizophrenia and intercurrent physical illness: a critical review of the literature. , 1977, Comprehensive psychiatry.

[14]  K. Vaddadi.  Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.

[15]  P. Kinnunen,et al.  Increased serum phospholipase A2 activity in schizophrenia: a replication study. , 1990, Biological psychiatry.

[16]  M. Murakami,et al.  Immunochemical detection of arachidonoyl-preferential phospholipase A2. , 1992, Journal of biochemistry.

[17]  R. Murray,et al.  A neurodevelopmental approach to the classification of schizophrenia. , 1992, Schizophrenia bulletin.

[18]  G. Vos.  Book reviewSchizophrenia, an international follow-up study: by World Health Organization, Geneva, New York, Wiley, New York, 1979. 438 pps. $16.00 , 1980 .

[19]  J. Haraldsdóttir,et al.  A new simplified dietary history method for measuring intake of energy and macronutrients. , 1992, European journal of clinical nutrition.

[20]  W. Gattaz,et al.  Increased platelet membrane lysophosphatidylcholine in schizophrenia , 1991, Biological Psychiatry.

[21]  D. Horrobin,et al.  Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia , 1991, Schizophrenia Research.

[22]  J. D. Clark,et al.  Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Vaddadi,et al.  A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia , 1989, Psychiatry Research.

[24]  D. Horrobin.  SCHIZOPHRENIA AS A PROSTAGLANDIN DEFICIENCY DISEASE , 1977, The Lancet.

[25]  W. Bunney,et al.  Reduced cyclic AMP production in the blood platelets from schizophrenic patients. , 1979, The American journal of psychiatry.

[26]  T. Goodfriend,et al.  Fatty Acid Effects on Angiotensin Receptors , 1986, Journal of cardiovascular pharmacology.

[27]  B. Koletzko.  Fats for brains. , 1992, European journal of clinical nutrition.

[28]  Y. Nishizuka,et al.  Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. , 1980, The Journal of biological chemistry.

[29]  V. Steen,et al.  Evidence that chlorpromazine and prostaglandin E1 but not neomycin interfere with the inositol phospholipid metabolism in intact human platelets , 1990, FEBS letters.

[30]  N. Minshew,et al.  31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. , 1993, Schizophrenia bulletin.

[31]  D. Horrobin,et al.  A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases , 1994, Schizophrenia Research.

[32]  D. Horrobin,et al.  Essential fatty acids in plasma phospholipids in schizophrenics , 1989, Biological Psychiatry.

[33]  W. Iacono,et al.  Where are the women in first-episode studies of schizophrenia? , 1992, Schizophrenia bulletin.

[34]  S. Hirsch,et al.  Inositol phospholipid turnover in platelets of schizophrenic patients. , 1992, Prostaglandins, Leukotrienes and Essential Fatty Acids.

[35]  J. Ishigooka,et al.  Different effects of centrally acting drugs on rabbit platelet aggregation: With special reference to selective inhibitory effects of antipsychotics and antidepressants , 1985, Biological Psychiatry.

[36]  Z. Herman,et al.  Effect of prostaglandins on chloropromazine induced catalepsy in mice. , 1983, Biomedica biochimica acta.

[37]  R. Gross,et al.  Cloning and expression of a human 14-3-3 protein mediating phospholipolysis. Identification of an arachidonoyl-enzyme intermediate during catalysis. , 1992, The Journal of biological chemistry.

[38]  J. D. Clark,et al.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP , 1991, Cell.

[39]  N. Uretsky,et al.  Prostaglandin inhibition of apomorphine-induced circling in mice , 1982, Pharmacology Biochemistry and Behavior.

[40]  M. Martres,et al.  Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism , 1991, Nature.

[41]  E. O'callaghan,et al.  Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. , 1992 .

[42]  J. Manetta,et al.  The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. , 1991, The Journal of biological chemistry.

[43]  F. Barrantes,et al.  Endogenous asymmetry of rat brain lipids and dominance of the right cerebral hemisphere in free fatty acid response to electroconvulsive shock , 1985, Brain Research.

[44]  J. Mccowan,et al.  Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents. , 1992, Journal of medicinal chemistry.

[45]  C. Cotman,et al.  Excitatory amino acid receptors in schizophrenia. , 1993, Schizophrenia bulletin.

[46]  E. Cantor-Graae,et al.  Head Circumference in ‘Preschizophrenic’ and Control Neonates , 1993, British Journal of Psychiatry.

[47]  R. Hass,et al.  Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association. , 1991, The Biochemical journal.

[48]  Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. , 1994 .

[49]  M. Keshavan,et al.  Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.

[50]  G. Rordorf,et al.  Characterization of phospholipase A2 (PLA2) activity in gerbil brain: enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[51]  E. Christensen,et al.  Fat consumption and schizophrenia , 1988, Acta psychiatrica Scandinavica.

[52]  D. Horrobin,et al.  Effects of dietary linoleic acid on growth and liver phospholipid fatty acid composition in intact and gonadectomized rats. , 1990 .

[53]  D. Horrobin,et al.  Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan , 1991, Biological Psychiatry.

[54]  R. G. Hoskins,et al.  ORGANIC FUNCTIONS IN SCHIZOPHRENIA , 1933 .

[55]  B. Cox,et al.  Reduction of opioid binding in neuroblastoma x glioma cells grown in medium containing unsaturated fatty acids. , 1982, Biochimica et biophysica acta.

[56]  R. Cantrill,et al.  Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices. , 1988, European journal of pharmacology.

[57]  F. Barrantes,et al.  Asymmetry of Diacylglycerol Metabolism in Rat Cerebral Hemispheres , 1986, Journal of neurochemistry.

[58]  J. Hunter,et al.  Are gender effects being neglected in schizophrenia research? , 1992, Schizophrenia bulletin.

[59]  S. Freedman,et al.  Specific Receptor‐Mediated Inhibition of Cyclic AMP Synthesis by Dopamine in a Neuroblastoma × Brain Hybrid Cell Line NCB‐20 , 1984, Journal of neurochemistry.

[60]  Keizō Inoue,et al.  Purification and characterization of human platelet phospholipase A2 which preferentially hydrolyzes an arachidonoyl residue , 1991, FEBS letters.